Targeting primary afferent nerves for novel antitussive therapy

Chest

Volumn 137, Issue 1, 2010, Pages 177-184

  Undem, Bradley J ^a   Carr, Michael J ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITUSSIVE AGENT; LIDOCAINE; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; VANILLOID RECEPTOR 1; VOLTAGE GATED SODIUM CHANNEL;

ACTION POTENTIAL; COUGHING; EVOKED RESPONSE; HUMAN; HYPERALGESIA; NERVE CELL EXCITABILITY; NERVE ENDING; NERVE FIBER C; NERVE STIMULATION; NEUROBIOLOGY; NONHUMAN; PRIMARY AFFERENT DEPOLARIZATION; PRIORITY JOURNAL; REVIEW; SENSORY NERVE; SENSORY NERVE CONDUCTION; SODIUM CURRENT; VAGUS NERVE; VAGUS NERVE STIMULATION; VAGUS REFLEX;

EID: 74949133882     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-1960     Document Type: Article

References (59)

1. Irwin RS, Baumann MH, Bolser DC, et al; American College of Chest Physicians (ACCP). Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1 suppl): 1S-23S.
2. Smith SM, Schroeder K, Fahey T. Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev. 2008;(1): CD001831.
3. Smith SM, Henman M, Schroeder K, Fahey T. Over-the-counter cough medicines in children: neither safe or efficacious? Br J Gen Pract. 2008; 58(556): 757-758.
4. Eccles R. Central mechanisms IV: conscious control of cough and the placebo effect. Handb Exp Pharmacol. 2009; 187: 241-262.
5. Stephens RE, Addington WR, Widdicombe JG. Effect of acute unilateral middle cerebral artery infarcts on voluntary cough and the laryngeal cough reflex. Am J Phys Med Rehabil. 2003; 82(5): 379-383.
6. Widdicombe JG. Respiratory reflexes from the trachea and bronchi of the cat. J Physiol. 1954; 123(1): 55-70.
7. Canning BJ, Mazzone SB, Meeker SN, Mori N, Reynolds SM, Undem BJ. Identification of the tracheal and laryngeal afferent neurones mediating cough in anaesthetized guineapigs. J Physiol. 2004; 557(pt 2): 543-558.
8. Tsubone H, Sant'Ambrogio G, Anderson JW, Orani GP. Laryngeal afferent activity and reflexes in the guinea pig. Respir Physiol. 1991; 86(2): 215-231.
9. Addington WR, Stephens RE, Widdicombe JG, Ockey RR, Anderson JW, Miller SP. Electrophysiologic latency to the external obliques of the laryngeal cough expiration reflex in humans. Am J Phys Med Rehabil. 2003; 82(5): 370-373.
10. Ho CY, Gu Q, Lin YS, Lee LY. Sensitivity of vagal afferent endings to chemical irritants in the rat lung. Respir Physiol. 2001; 127(2-3): 113-124.
11. Canning BJ. Interactions between vagal afferent nerve subtypes mediating cough. Pulm Pharmacol Ther. 2002; 15(3): 187-192.
12. Mazzone SB, Mori N, Canning BJ. Synergistic interactions between airway afferent nerve subtypes regulating the cough reflex in guinea-pigs. J Physiol. 2005; 569(Pt 2): 559-573.
13. Plevkova J, Antosiewicz J, Varechova S, et al. Convergence of nasal and tracheal neural pathways in modulating the cough response in guinea pigs. J Physiol Pharmacol. 2009; 60(2): 89-93.
14. Kollarik M, Brozmanova M. Cough and gastroesophageal reflux: insights from animal models. Pulm Pharmacol Ther. 2009; 22(2): 130-134.
15. Kwong K, Kollarik M, Nassenstein C, Ru F, Undem BJ. P2X2 receptors differentiate placodal vs. neural crest C-fiber phenotypes innervating guinea pig lungs and esophagus. Am J Physiol Lung Cell Mol Physiol. 2008; 295(5): L858-L865.
16. Canning BJ, Chou YL. Cough sensors. I. Physiological and pharmacological properties of the afferent nerves regulating cough. Handb Exp Pharmacol. 2009; 187: 23-47.
17. Tatar M, Webber SE, Widdicombe JG. Lung C-fibre receptor activation and defensive reflexes in anaesthetized cats. J Physiol. 1988; 402(1): 411-420.
18. Kajekar R, Proud D, Myers AC, Meeker SN, Undem BJ. Characterization of vagal afferent subtypes stimulated by bradykinin in guinea pig trachea. J Pharmacol Exp Ther. 1999; 289(2): 682-687.
19. Fox AJ, Barnes PJ, Venkatesan P, Belvisi MG. Activation of large conductance potassium channels inhibits the afferent and efferent function of airway sensory nerves in the guinea pig. J Clin Invest. 1997; 99(3): 513-519.
20. Lee MG, Undem BJ, Brown C, Carr MJ. Effect of nociceptin in acid-evoked cough and airway sensory nerve activation in guinea pigs. Am J Respir Crit Care Med. 2006; 173(3): 271-275.
21. Collier JG, Fuller RW. Capsaicin inhalation in man and the effects of sodium cromoglycate. Br J Pharmacol. 1984; 81(1): 113-117.
22. Gunthorpe MJ, Chizh BA. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway. Drug Discov Today. 2009; 14(1-2): 56-67.
23. Gavva NR, Bannon AW, Hovland DN Jr, et al. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade. J Pharmacol Exp Ther. 2007; 323(1): 128-137.
24. Gavva NR, Treanor JJ, Garami A, et al. Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain. 2008; 136(1-2): 202-210.
25. 1H-inden-4-yl)-3-(2-(piperidin-1-yl)- 4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats. J Pharmacol Exp Ther. 2008; 326(1): 218-229.
26. Bandell M, Story GM, Hwang SW, et al. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron. 2004; 41(6): 849-857.
27. Jordt SE, Bautista DM, Chuang HH, et al. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature. 2004; 427(6971): 260-265.
28. McNamara CR, Mandel-Brehm J, Bautista DM, et al. TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci USA. 2007; 104(33): 13525-13530.
29. Taylor-Clark TE, Kiros F, Carr MJ, McAlexander MA. Transient receptor potential ankyrin 1 mediates toluene diisocyanate-evoked respiratory irritation. Am J Respir Cell Mol Biol. 2009; 40(6): 756-762.
30. Sim VM, Pattle RE. Effect of possible smog irritants on human subjects. J Am Med Assoc. 1957; 165(15): 1908-1913.
31. Lee BP, Morton RF, Lee LY. Acute effects of acrolein on breathing: role of vagal bronchopulmonary afferents. J Appl Physiol. 1992; 72(3): 1050-1056.
32. Symanowicz PT, Gianutsos G, Morris JB. Lack of role for the vanilloid receptor in response to several inspired irritant air pollutants in the C57Bl/6J mouse. Neurosci Lett. 2004; 362(2): 150-153.
33. Birrell MA, Belvisi MG, Grace M, et al. TRPA1 agonists evoke coughing in guinea-pig and human volunteers. Am J Respir Crit Care Med. 2009; 180(11): 1040-1047.
34. Macpherson LJ, Dubin AE, Evans MJ, et al. Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature. 2007; 445(7127): 541-545.
35. Hinman A, Chuang HH, Bautista DM, Julius D. TRP channel activation by reversible covalent modification. Proc Natl Acad Sci USA. 2006; 103(51): 19564-19568.
36. Taylor-Clark TE, McAlexander MA, Nassenstein C, et al. Relative contributions of TRPA1 and TRPV1 channels in the activation of vagal bronchopulmonary C-fibres by the endogenous autacoid 4-oxononenal. J Physiol. 2008; 586(14): 3447-3459.
37. Taylor-Clark TE, Undem BJ, Macglashan DW, Jr, Ghatta S, Carr MJ, McAlexander MA. Prostaglandin-induced activation of nociceptive neurons via direct interaction with transient receptor potential A1(TRPA1). Mol Pharmacol. 2008; 73(2): 274-281.
38. Taylor-Clark TE, Ghatta S, Bettner W, Undem BJ. Nitrooleic acid, an endogenous product of nitrative stress, activates nociceptive sensory nerves via the direct activation of TRPA1. Mol Pharmacol. 2009; 75(4): 820-829.
39. Eid SR, Crown ED, Moore EL, et al. HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity. Mol Pain. 2008; 4: 48.
40. Petrus M, Peier AM, Bandell M, et al. A role of TRPA1 in mechanical hyperalgesia is revealed by pharmacological inhibition. Mol Pain. 2007; 3: 40.
41. McCleane G. Intravenous lidocaine: an outdated or under-utilized treatment for pain? J Palliat Med. 2007; 10(3): 798-805.
42. Kwong K, Carr MJ, Gibbard A, et al. Voltage-gated sodium channels in nociceptive versus non-nociceptive nodose vagal sensory neurons innervating guinea pig lungs. J Physiol. 2008; 586(5): 1321-1336.
43. Raymond CK, Castle J, Garrett-Engele P, et al. Expression of alternatively spliced sodium channel alpha-subunit genes. Unique splicing patterns are observed in dorsal root ganglia. J Biol Chem. 2004; 279(44): 46234-46241.
44. Ahmad S, Dahllund L, Eriksson AB, et al. A stop codon mutation in SCN9A causes lack of pain sensation. Hum Mol Genet. 2007; 16(17): 2114-2121.
45. Cox JJ, Reimann F, Nicholas AK, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature. 2006; 444(7121): 894-898.
46. Cummins TR, Howe JR, Waxman SG. Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. J Neurosci. 1998; 18(23): 9607-9619.
47. Akopian AN, Souslova V, England S, et al. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci. 1999; 2(6): 541-548.
48. Renganathan M, Cummins TR, Waxman SG. Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons. J Neurophysiol. 2001; 86(2): 629-640.
49. Gold MS, Levine JD, Correa AM. Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. J Neurosci. 1998; 18(24): 10345-10355.
50. Kwong K, Lee LY. Prostaglandin E2 potentiates a TTX-resistant sodium current in rat capsaicin-sensitive vagal pulmonary sensory neurones. J Physiol. 2005; 564(Pt 2): 437-450.
51. Jarvis MF, Honore P, Shieh CC, et al. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci USA. 2007; 104(20): 8520-8525.
52. Herzog RI, Cummins TR, Waxman SG. Persistent TTX-resistant Na+ current affects resting potential and response to depolarization in simulated spinal sensory neurons. J Neurophysiol. 2001; 86(3): 1351-1364.
53. Cummins TR, Dib-Hajj SD, Black JA, Akopian AN, Wood JN, Waxman SG. A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons. J Neurosci. 1999; 19(24): RC43.
54. Cummins TR, Black JA, Dib-Hajj SD, Waxman SG. Glial-derived neurotrophic factor upregulates expression of functional SNS and NaN sodium channels and their currents in axotomized dorsal root ganglion neurons. J Neurosci. 2000; 20(23): 8754-8761.
55. Rush AM, Waxman SG. PGE2 increases the tetrodotoxin-resistant Nav1.9 sodium current in mouse DRG neurons via G-proteins. Brain Res. 2004; 1023(2): 264-271.
56. Maingret F, Coste B, Padilla F, et al. Inflammatory mediators increase Nav1.9 current and excitability in nociceptors through a coincident detection mechanism. J Gen Physiol. 2008; 131(3): 211-225.
57. Amaya F, Wang H, Costigan M, et al. The voltage-gated sodium channel Na(v)1.9 is an effector of peripheral inflammatory pain hypersensitivity. J Neurosci. 2006; 26(50): 12852-12860.
58. Priest BT, Murphy BA, Lindia JA, et al. Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior. Proc Natl Acad Sci USA. 2005; 102(26): 9382-9387.
59. Ghatta S, McAlexander MA, Carr MJ. Characterization of vagal afferent neurons from NaV1.9 -/- and NaV1.9 +/+ mice [abstract]. http://sfn.org/am2008. Accessed August 2009.